Basics BioXcel Therapeutics, Inc. IPO Date: March 5, 2018 Sector: Healthcare Industry: Biotech Market Cap: $55.17M Activated in VL: True Average Daily Range Avg Daily Range: $0.62 | 4.25% Avg Daily Range (30 D): $0.44 | 11.57% Avg Daily Range (90 D): $0.20 | 6.98% Institutional Daily Volume Avg Daily Volume: .91M Avg Daily Volume (30 D): 15.6M Avg Daily Volume (90 D): 5.48M Trade Size Avg Trade Size (Sh.): 136 Avg Trade Size (Sh.) (30 D): 196 Avg Trade Size (Sh.) (90 D): 194 Institutional Trades Total Inst.Trades: 907 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.72M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $.5M Avg Closing Trade (90 D): $.5M Avg Closing Volume: 4.12K     News Aug 27, 2025 @ 12:00 PM UPDATE -- BioXcel Therapeutics Announces SERENITY ... Source: Bioxcel Therapeutics Aug 26, 2025 @ 8:00 PM BioXcel Therapeutics To Announce Topline Results f... Source: Bioxcel Therapeutics, Inc. Aug 18, 2025 @ 11:00 AM BioXcel Therapeutics Announces Positive FDA Pre-sN... Source: Bioxcel Therapeutics Aug 13, 2025 @ 4:33 PM 3 Supercharged Stocks Flashing Strong Momentum Sig... Source: Adam Eckert Aug 4, 2025 @ 5:00 PM Neuroendocrine Prostate Cancer Market Forecast Sho... Source: Delveinsight Financials   TTM Q2 2025 Q1 2025 Basic EPS $-26.49 $-2.45 $-1.5 Diluted EPS $-26.49 $-2.45 $-1.5 Revenue $ .87M $ .12M $ .17M Gross Profit $ -1.26M $ .01M $ .15M Net Income / Loss $ -50.95M $ -19.19M $ -7.25M Operating Income / Loss $ -51.74M $ -15.85M $ -10.1M Cost of Revenue $ 2.12M $ .11M $ .01M Net Cash Flow $ M $ M $ M PE Ratio     Splits Feb 10, 2025:   1:16